By Staff writer
Clinical trials for phase three testing being conducted by Abu Dhabi Health Services
Over 10,000 people across the UAE have volunteered to take part in clinical trials for phase three testing of a vaccine to combat Covid-19.
The trials are being conducted by Abu Dhabi Health Services (SEHA) under the supervision of the Department of Health – Abu Dhabi, and in collaboration with G42’s Sinopharm CNBG.
Dr. Jamal Mohammed Al Kaabi, acting undersecretary of DOH, said: "The diversity of nationalities that call the UAE home, as well as the leading role our leadership plays in tackling the virus in various countries of the world, made the country the perfect place for phase III of the clinical trials.”
Al Kaabi commended the "overwhelming response" by Emiratis and residents to the call for volunteers.
"The trials attracted volunteers from over 20 nationalities which is a positive sign for an increasingly feasible vaccine," he added.
Up to 15,000 volunteers are being sought to take part in the trial with a minimum of 5,000 participants in the first stage of the programme to ensure the robustness of the results.
There have been 58,249 cases of coronavirus reported in the UAE since the onset of the pandemic, which has claimed the lives of 343 people so far.